Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15771429rdf:typepubmed:Citationlld:pubmed
pubmed-article:15771429lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C0020205lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C0002302lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C0017048lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C1417061lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C1417063lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C0181586lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C0599740lld:lifeskim
pubmed-article:15771429lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:15771429pubmed:issue6lld:pubmed
pubmed-article:15771429pubmed:dateCreated2005-3-17lld:pubmed
pubmed-article:15771429pubmed:abstractTextTo further evaluate elements that could contribute to the 3D topographical structure of gamma-MSH, we have systematically designed a group of linear gamma-MSH analogues and evaluated their biological activities: without a N-terminal acetyl, with and without a C-terminal amide, with Nle(3), with l- or d-Phe(6) or d-Nal(2')(6), and with d-Trp(8) or d-Nal(2')(8). It was found that changing the C-terminal acid in gamma-MSH to an amide and replacing Met with Nle leads to increased binding affinities at all four subtypes of melanocortin receptors (10-100 fold). Substitution of Trp(8) with d-Nal(2')(8) and Phe(6) with d-Phe(6) in gamma-MSH-NH(2) forms a selective antagonist for the hMC3R, whereas, substitution of Phe(6) with d-Nal(2')(6) and replacing Trp(8) with d-Trp(8) at gamma-MSH-NH(2) yields a selective partial agonist for the hMC1R. Finally, substitution of His(5) with Pro(5) and Trp(8) with d-Nal(2')(8) in gamma-MSH-NH(2) leads to a highly potent and selective agonist for the hMC1R. Molecular modeling showed that, at the C-terminal of Nle(3)-gamma-MSH-NH(2), there is a reverse-turn-like structure, suggesting that there might be a secondary binding site involved in ligand-receptor interaction for gamma-MSH analogues that may explain the enhanced binding affinities of the Nle(3)-gamma-MSH-NH(2) analogues. Our results indicate that increasing the hydrophobicity and replacing Phe(6) and Trp(8) with bulkier aromatic amino acid residues is very important for selectivity of alpha-MSH/gamma-MSH hybrids for hMCRs.lld:pubmed
pubmed-article:15771429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:languageenglld:pubmed
pubmed-article:15771429pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:citationSubsetIMlld:pubmed
pubmed-article:15771429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15771429pubmed:statusMEDLINElld:pubmed
pubmed-article:15771429pubmed:monthMarlld:pubmed
pubmed-article:15771429pubmed:issn0022-2623lld:pubmed
pubmed-article:15771429pubmed:authorpubmed-author:HrubyVictor...lld:pubmed
pubmed-article:15771429pubmed:authorpubmed-author:TrivediDevDlld:pubmed
pubmed-article:15771429pubmed:authorpubmed-author:CaiMinyingMlld:pubmed
pubmed-article:15771429pubmed:authorpubmed-author:CabelloChrist...lld:pubmed
pubmed-article:15771429pubmed:authorpubmed-author:StankovaMagda...lld:pubmed
pubmed-article:15771429pubmed:authorpubmed-author:MayorovAlexan...lld:pubmed
pubmed-article:15771429pubmed:issnTypePrintlld:pubmed
pubmed-article:15771429pubmed:day24lld:pubmed
pubmed-article:15771429pubmed:volume48lld:pubmed
pubmed-article:15771429pubmed:ownerNLMlld:pubmed
pubmed-article:15771429pubmed:authorsCompleteYlld:pubmed
pubmed-article:15771429pubmed:pagination1839-48lld:pubmed
pubmed-article:15771429pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:meshHeadingpubmed-meshheading:15771429...lld:pubmed
pubmed-article:15771429pubmed:year2005lld:pubmed
pubmed-article:15771429pubmed:articleTitleNovel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues.lld:pubmed
pubmed-article:15771429pubmed:affiliationDepartment of Chemistry, University of Arizona, Tucson, Arizona 85721, USA.lld:pubmed
pubmed-article:15771429pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15771429pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:15771429lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15771429lld:pubmed